FIELD: chemistry.
SUBSTANCE: invention relates to octapeptides of formula (I), where X and Y=H or a chelating group, particularly DOTA, covalently bonded with α- or ε-amino groups of N-terminal lysine, which are octreotide derivatives, as well as radiotracers based thereon, used in tumour diagnosis. The octapeptide of formula (I) forms a chelate complex with radionuclides, for example in form of gallium isotopes 68Ga, 66Ga, 67Ga to obtain a radiopharmaceutical complex. The radiotracer is used for diagnosis of tumours expressing somatostatin receptors or metastases thereof.
EFFECT: improved method.
4 cl, 8 ex, 3 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
CYCLIC OCTAPEPTIDE, RADIOPHARMACEUTICAL AGENT BASED THEREON AND METHOD OF USING RADIOPHARMACEUTICAL AGENT TO PRODUCE MEDICINAL (PHARMACEUTICAL) AGENTS FOR TREATING NEOPLASMS EXPRESSING SOMATOSTATIN RECEPTORS | 2013 |
|
RU2528414C1 |
PHARMACEUTICAL RADIOPREPARATION FOR DIAGNOSING MELANOMA AND ITS METASTASES | 2011 |
|
RU2465011C1 |
RADIOPHARMACEUTICAL FOR THE DIAGNOSIS OF PROSTATE CANCER BY POSITRON EMISSION TOMOGRAPHY AND METHOD FOR ITS PRODUCTION | 2022 |
|
RU2796106C1 |
SOMASTATINIC PEPTIDES, RADIOPHARMACEUTICAL AGENT, METHOD OF TREATING TUMORS, AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2156774C2 |
LYOPHILIZATE FOR PREPARING RADIOPHARMACEUTICAL AGENT | 2017 |
|
RU2702238C2 |
GRPR ANTAGONISTS FOR DETECTING, DIAGNOSING AND TREATING GRPR-POSITIVE ONCOLOGICAL DISEASE | 2013 |
|
RU2693465C2 |
GRPR ANTAGONISTS FOR DETECTING, DIAGNOSING AND TREATING GRPR-POSITIVE ONCOLOGICAL DISEASE | 2013 |
|
RU2821944C2 |
OSTEOTROPIC RADIOPHARMACEUTICALS FOR PET IMAGING | 2014 |
|
RU2614235C2 |
METHOD FOR PRODUCING COMPLEXES BASED ON GALLIUM-68 ISOTOPE | 2020 |
|
RU2760273C1 |
SOMATOSTATINE PEPTIDES | 1996 |
|
RU2160741C2 |
Authors
Dates
2012-07-27—Published
2011-04-07—Filed